from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3125c/PPE49

LFCtreatmentdescriptionclass of inhibitor

0.368

Amikacinug/mL Amikacintranslation

0.137

Cap5-10ug/mL Capreomycintranslation

-0.490

Rox10-50 ug/mL Roxithromycintranslation

0.203

SM2-5 ug/mL Streptomycintranslation

2.058

Tet5-10 ug/mL Tetracyclinetranslation

0.060

Rif0.2-5ug/mL Rifampicintranscription

0.184

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.947

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.263

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.006

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.316

Clofazimine10-13 ug/mL Clofaziminerespiration

0.310

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.548

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.944

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.517

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.453

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.423

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.150

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.059

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.106

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.864

KCN5-20 ug/mL Potassium cyaniderespiration

-0.303

NaN30.2-2 mM Sodium aziderespiration

0.063

Nigericin50 uM Nigericinrespiration

0.038

TRC10-150 ug/mL Triclosanrespiration

0.020

TRZ10-25 ug/mL Thioridazinerespiration

-0.274

Valinomycin0.5-10 uM Valinomycinrespiration

5.258

ZnSO42 mM ZnSO4respiration

0.586

menadione6-10 ug/mL Menadionerespiration

0.111

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.128

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.638

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.224

NRP_1Non-replicating persistence stage 1dosRassociated

-0.154

Amp0.2mg/mL AmpicillincellWall

0.018

Cephalexin20-100 ug/mL CephalexincellWall

1.673

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.771

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.605

EMB10-20 ug/mL EthambutolcellWall

0.189

Eta12-40 ug/mL EthionamidecellWall

0.143

INH0.2-0.4 ug/mL IsoniazidcellWall

0.182

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.492

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.179

BZA0.12 mg/mL BenzamidearomaticAmides

-0.155

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.175

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.636

H2O24 mM hydrogen peroxideDNAdamaging

0.041

Levo10 ug/mL LevofloxacinDNAdamaging

-0.099

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.454

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.420

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.188

UVUV-irradiationDNAdamaging

-0.873

ARP41-4 ug/mL Antitubercular compound ARP4?

0.212

Antimycin12.5-50 ug/mL Antimycin A?

-0.113

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.122

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.146

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.151

PA8240.2-2 ug/mL PA-824?

0.240

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.576

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.393

Verapamil50 uM Verapamil?

-0.064

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.649

methoxatin10-20 ug/mL Methoxatin?